Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Dynamic contrast-enhanced T1-weighted perfusion MR imaging identifies glioblastoma immunohistochemical biomarkers via tumoral and peritumoral approach: A pilot study.

Ozturk K, Soylu E, Tolunay S, Narter S, Hakyemez B.

World Neurosurg. 2019 Apr 16. pii: S1878-8750(19)31081-2. doi: 10.1016/j.wneu.2019.04.089. [Epub ahead of print]

PMID:
31003026
2.

Case Report: Ductal Carcinoma in Situ Within A Granulomatous Mastitis.

Özşen M, Tolunay Ş, Gökgöz MŞ.

Eur J Breast Health. 2018 Jul 1;14(3):186-188. doi: 10.5152/ejbh.2018.3894. eCollection 2018 Jul.

3.

Granulomatous Lobular Mastitis: Clinicopathologic Presentation of 90 Cases

Özşen M, Tolunay Ş, Gökgöz MŞ.

Turk Patoloji Derg. 2018;34(3):215-219. doi: 10.5146/tjpath.2018.01431. Review.

4.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW.

Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14.

5.

Olea europaea Leaf Extract Improves the Efficacy of Temozolomide Therapy by Inducing MGMT Methylation and Reducing P53 Expression in Glioblastoma.

Tezcan G, Tunca B, Demirci H, Bekar A, Taskapilioglu MO, Kocaeli H, Egeli U, Cecener G, Tolunay S, Vatan O.

Nutr Cancer. 2017 Aug-Sep;69(6):873-880. doi: 10.1080/01635581.2017.1339810. Epub 2017 Jul 18.

PMID:
28718668
6.

Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro.

Tezcan G, Taskapilioglu MO, Tunca B, Bekar A, Demirci H, Kocaeli H, Aksoy SA, Egeli U, Cecener G, Tolunay S.

Biomed Pharmacother. 2017 Jun;90:713-723. doi: 10.1016/j.biopha.2017.04.022. Epub 2017 Apr 15.

PMID:
28419967
7.

Leptomeningeal dissemination and vertebral bone involvement in a child with pilocytic astrocytoma.

Demirkaya M, Sevinir B, Güler S, Demiröz C, Taskapilioglu Ö, Yilmazlar S, Palabiyik F, Tolunay S.

Pediatr Int. 2016 Dec;58(12):1341-1344. doi: 10.1111/ped.13121. Epub 2016 Nov 13.

PMID:
27859985
8.

Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.

Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.

Asian Pac J Cancer Prev. 2016;17(9):4241-4246.

9.

Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer.

Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, Hartavi M, Fatih Olmez O, Kurt E, Tolunay S, Kanat O, Manavoglu O.

J BUON. 2016 May-Jun;21(3):564-9.

10.

Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.

Sevinc ED, Cecener G, Ak S, Tunca B, Egeli U, Gokgoz S, Tolunay S, Tasdelen I.

Gene. 2016 Sep 30;590(2):278-84. doi: 10.1016/j.gene.2016.05.033. Epub 2016 May 25.

PMID:
27236032
11.

Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy.

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Altmisdortoglu O, Tanriverdi O, Aksoy A, Kurt E, Evrensel T.

J BUON. 2015 Jul-Aug;20(4):994-1000.

12.

Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T.

J BUON. 2015 Jan-Feb;20(1):45-9.

13.

Association of miR-1266 with recurrence/metastasis potential in estrogen receptor positive breast cancer patients.

Sevinc ED, Egeli U, Cecener G, Tezcan G, Tunca B, Gokgoz S, Tasdelen I, Tolunay S, Evrensel T.

Asian Pac J Cancer Prev. 2015;16(1):291-7.

14.

BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.

Erturk E, Cecener G, Tezcan G, Egeli U, Tunca B, Gokgoz S, Tolunay S, Tasdelen I.

Gene. 2015 Feb 10;556(2):163-9. doi: 10.1016/j.gene.2014.11.047. Epub 2014 Nov 22.

PMID:
25445393
15.

Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.

Tezcan G, Tunca B, Bekar A, Budak F, Sahin S, Cecener G, Egeli U, Taskapılıoglu MO, Kocaeli H, Tolunay S, Malyer H, Demir C, Tumen G.

Am J Cancer Res. 2014 Sep 6;4(5):572-90. eCollection 2014.

16.

Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations.

Erturk E, Cecener G, Egeli U, Tunca B, Tezcan G, Gokgoz S, Tolunay S, Tasdelen I.

Mol Cell Biochem. 2014 Oct;395(1-2):77-88. doi: 10.1007/s11010-014-2113-4. Epub 2014 Jun 19.

PMID:
24942235
17.

microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.

Tezcan G, Tunca B, Bekar A, Preusser M, Berghoff AS, Egeli U, Cecener G, Ricken G, Budak F, Taskapılıoglu MO, Kocaeli H, Tolunay S.

Cell Mol Neurobiol. 2014 Jul;34(5):679-92. doi: 10.1007/s10571-014-0050-0. Epub 2014 Apr 2.

PMID:
24691539
18.

Intracranial extra-axial chondroma: a case report.

Atalay FO, Ozgun G, Tolunay S, Bekar A.

J Nippon Med Sch. 2014;81(1):35-9.

19.

Incidentally Discovered Extensive Squamous Metaplasia within Borderline Phyllodes Tumor: Presentation of a Rare Tumor.

Uğraş N, Tolunay Ş, Öz Atalay F, Gökgöz Ş.

Turk Patoloji Derg. 2016;32(1):47-50. doi: 10.5146/tjpath.2014.01225.

20.

Multiple extracranial metastases from secondary glioblastoma: a case report and review of the literature.

Taskapilioglu MO, Aktas U, Eser P, Tolunay S, Bekar A.

Turk Neurosurg. 2013;23(6):824-7. doi: 10.5137/1019-5149.JTN.6497-12.1.

21.

Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.

Taşkapilioğlu Ö, Seferoğlu M, Yurtoğullari Ş, Hakyemez B, Erer S, Karli N, Bakar M, Turan ÖF, Zarifoğlu M, Tolunay Ş, Bora İ.

Noro Psikiyatr Ars. 2013 Dec;50(4):306-311. doi: 10.4274/Npa.y5903. Epub 2013 Dec 1.

22.

Creutzfeldt-Jakob disease: report of four cases and review of the literature.

Atalay FÖ, Tolunay Ş, Özgün G, Bekar A, Zarifoğlu M.

Turk Patoloji Derg. 2015;31(2):148-52. doi: 10.5146/tjpath.2013.01195. Review.

23.
24.

Prognostic significance of human epidermal receptor (HER)- 3 immunohistochemical expression in patients with metastatic breast cancer.

Olmez OF, Evrensel T, Cubukcu E, Ugras N, Avci N, Canhoroz M, Deligonul A, Hartavi M, Olmez F, Cubukcu S, Tolunay S, Kurt E, Kanat O, Manavoglu O.

Asian Pac J Cancer Prev. 2013;14(7):4115-9.

25.

The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme.

Olmez OF, Cubukcu E, Evrensel T, Kurt M, Avci N, Tolunay S, Bekar A, Deligonul A, Hartavi M, Alkis N, Manavoglu O.

Clin Transl Oncol. 2014 Feb;16(2):173-7. doi: 10.1007/s12094-013-1059-4. Epub 2013 Jun 6.

PMID:
23740136
26.

Prevention of epidural fibrosis in rats by local or systemic administration of citicoline.

Savran M, Bekar A, Cansev M, Tolunay S, Ulus IH, Taskapilioglu MO.

Turk Neurosurg. 2012;22(5):634-40. doi: 10.5137/1019-5149.JTN.6008-12.0.

27.

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

Tunca B, Egeli U, Cecener G, Tezcan G, Gökgöz S, Tasdelen I, Bayram N, Tolunay S, Umut G, Demirdogen E, Erturk E, Ak S, Cetintas S, Evrensel T.

Tumori. 2012 Mar-Apr;98(2):243-51. doi: 10.1700/1088.11937.

PMID:
22677992
28.
29.

Primary small cell carcinoma of the breast: report of seven cases and review of the literature.

Kanat O, Kilickap S, Korkmaz T, Ustaalioglu Oven BB, Canhoroz M, Cubukcu E, Tolunay S, Evrensel T, Manavoglu O.

Tumori. 2011 Jul-Aug;97(4):473-8. doi: 10.1700/950.10400. Review.

PMID:
21989436
30.

Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study.

Tihan T, Ersen A, Qaddoumi I, Sughayer MA, Tolunay S, Al-Hussaini M, Phillips J, Gupta N, Goldhoff P, Baneerjee A.

Am J Surg Pathol. 2012 Jan;36(1):43-55. doi: 10.1097/PAS.0b013e3182329480.

PMID:
21989351
31.

The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Cecener G, Tunca B, Egeli U, Bekar A, Tezcan G, Erturk E, Bayram N, Tolunay S.

Cell Mol Neurobiol. 2012 Mar;32(2):237-44. doi: 10.1007/s10571-011-9753-7. Epub 2011 Sep 18.

PMID:
21928112
32.

CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves.

Aslan E, Kocaeli H, Bekar A, Tolunay S, Ulus IH.

Neurol Res. 2011 Sep;33(7):766-73. doi: 10.1179/1743132811Y.0000000004.

PMID:
21756558
33.

Isolated sixth nerve palsy due to plasma cell granuloma in the sphenoid sinus: case report and review of the literature.

Taskapilioglu O, Yurtogullari S, Yilmaz E, Hakyemez B, Yilmazlar S, Tolunay S, Turan F, Bora I.

Clin Neuroradiol. 2011 Nov;21(4):235-8. doi: 10.1007/s00062-011-0054-9. Epub 2011 Mar 1. Review. No abstract available.

PMID:
21360227
34.

Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.

Gokalp G, Topal U, Yildirim N, Tolunay S.

Eur J Radiol. 2012 Feb;81(2):203-8. doi: 10.1016/j.ejrad.2010.12.022. Epub 2011 Jan 13.

PMID:
21236612
35.

Metastatic gliosarcoma mass extension to a donor fascia lata graft harvest site by tumor cell contamination.

Bekar A, Kahveci R, Tolunay S, Kahraman A, Kuytu T.

World Neurosurg. 2010 Jun;73(6):719-21. doi: 10.1016/j.wneu.2010.03.015.

PMID:
20934163
36.

Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.

Kutuk O, Temel SG, Tolunay S, Basaga H.

Eur J Cancer. 2010 Sep;46(13):2494-505. doi: 10.1016/j.ejca.2010.06.011. Epub 2010 Jul 7.

PMID:
20619636
37.

Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats.

Abas F, Alkan T, Goren B, Taskapilioglu O, Sarandol E, Tolunay S.

Turk Neurosurg. 2010 Jan;20(1):1-8.

38.

Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats.

Sahin S, Alkan T, Temel SG, Tureyen K, Tolunay S, Korfali E.

J Clin Neurosci. 2010 Feb;17(2):227-31. doi: 10.1016/j.jocn.2009.05.016. Epub 2009 Dec 24.

PMID:
20036128
39.

FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme.

Cecener G, Tunca B, Egeli U, Bekar A, Guler G, Tolunay S, Aksoy K.

Cell Mol Neurobiol. 2010 Mar;30(2):301-7. doi: 10.1007/s10571-009-9452-9. Epub 2009 Sep 17.

PMID:
19760177
40.

Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas.

Cecener G, Tunca B, Egeli U, Bekar A, Guler G, Vatan O, Tolunay S.

Cell Mol Neurobiol. 2009 Jul;29(5):733-8. doi: 10.1007/s10571-009-9397-z. Epub 2009 Apr 7.

PMID:
19350382
41.

Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.

Cecener G, Tunca B, Egeli U, Karadag M, Vatan O, Uzaslan E, Tolunay S.

Tumori. 2008 Nov-Dec;94(6):845-8.

PMID:
19267103
42.

Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.

Bekar A, Ceçener G, Tunca B, Guler G, Egeli U, Tolunay S.

Tumori. 2007 Nov-Dec;93(6):604-7.

PMID:
18338497
43.

Importance of novel sequence alterations in the FHIT gene on formation of breast cancer.

Ceçener G, Egeli U, Tunca B, Taşdelen I, Tolunay S, Bilgel N.

Tumori. 2007 Nov-Dec;93(6):597-603.

PMID:
18338496
44.

Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas.

Yakut T, Gutenberg A, Bekar A, Egeli U, Gunawan B, Ercan I, Tolunay S, Doygun M, Schulten HJ.

Oncol Rep. 2007 May;17(5):1037-43.

PMID:
17390041
45.

Isolated intrasellar tuberculoma mimicking pituitary adenoma.

Yilmazlar S, Bekar A, Taskapilioglu O, Tolunay S.

J Clin Neurosci. 2007 May;14(5):477-81. Epub 2007 Mar 7.

PMID:
17346976
46.

Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme.

Tunca B, Bekar A, Cecener G, Egeli U, Vatan O, Tolunay S, Kocaeli H, Aksoy K.

J Neurooncol. 2007 May;82(3):263-9. Epub 2006 Dec 7.

PMID:
17151929
47.

Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.

Kocaeli H, Yakut T, Bekar A, Taşkapilioğlu O, Tolunay S.

Surg Neurol. 2006 Dec;66(6):627-30; discussion 630-1. Epub 2006 Oct 6.

PMID:
17145331
48.

Therapeutic effect of hypothermia and dizocilpine maleate on traumatic brain injury in neonatal rats.

Celik SE, Oztürk H, Tolunay S.

J Neurotrauma. 2006 Sep;23(9):1355-65.

PMID:
16958587
49.

Primary pulmonary amyloidosis associated with multiple myeloma.

Ege E, Uzaslan E, Ursavaş A, Güçlü M, Ozkalemkaş F, Tolunay S.

Tuberk Toraks. 2006;54(1):65-70.

PMID:
16615021
50.

Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.

Demiray M, Kurt E, Evrensel T, Kanat O, Arslan M, Saraydaroglu O, Ercan I, Gonullu G, Gokgoz S, Topal U, Tolunay S, Tasdelen I, Manavoglu O.

Cancer Invest. 2005;23(5):386-91.

PMID:
16193637

Supplemental Content

Loading ...
Support Center